MK 458,
MK-458,
NAXAGOLIDE HYDROCHLORIDE,
ent Naxagolide Hydrochloride,
99705-65-4,
Naxagolide HCl,
100935-99-7,
UNII-E5KFJ9796W,
MK-458,
(+)-PHNO Hydrochloride,
MK 458,
E5KFJ9796W,
Naxagolide hydrochloride [USAN],
L-647339,
Naxagolide hydrochloride (USAN),
(4aR,10bR)-4-propyl-3,4,4a,5,6,10b-hexahydro-2H-naphtho[1,2-b][1,4]oxazin-9-ol hydrochloride,
Nazagolide HCl,
Dopazinol Hydrochloride,
entNaxagolideHydrochloride,
AC1L1N6X,
(+/-)-PHNO hydrochloride,
MLS006010256,
SCHEMBL122853,
L 647,339,
PHNO-(+),
CHEMBL2106804,
CTK8E7920,
DTXSID60244221,
BCP25707,
AKOS030254483,
(+)-(4aR,10bR)-3,4,4a,5,6,10b-Hexahydro-4-propyl-2H-naphth(1,2-b)-1,4-oxazin-9-ol hydrochloride,
4CA-0896,
SMR004701331,
RT-012468,
D05124,
(+)-Propyl-9-hydroxynaphthoxazine Hydrochloride,
J-000279,
L 647339,
L-647,339,
N-0500-(+),
(4aR,10bR)-4-propyl-2,3,4a,5,6,10b-hexahydrobenzo[h][1,4]benzoxazin-9-ol hydrochloride,
(4aR-trans)-3,4,4a,5,6,10b-Hexahydro-4-propyl-2H-naphth[1,2-b]-1,4-oxazin-9-ol Hydrochloride,
2H-Naphth(1,2-b)-1,4-oxazin-9-ol, 3,4,4a,5,6,10b-hexahydro-4-propyl-, hydrochloride, (4aR-trans)-,
2H-Naphth[1,2-b]-1,4-oxazin-9-ol, 3,4,4a,5,6,10b-hexahydro-4-propyl-, hydrochloride, trans- (9CI),
88058-85-9,
trans-(+/-)-4-Propyl-3,4,4a,5,6,10b-hexahydro-2H-naphtho[1,2-b][1,4]oxazin-9-ol hydrochloride,
dopazinol,
NAXAGOLIDE,
cc-181,
C15-H21-N-O2.Cl-H,
MK458,
CID57532,
LY404039,
635318-55-7,
88058-88-2,